We Are Closely Following These 13 Cannabis Markets In The US

Although 2022 was a tough period for cannabis stocks, the United States (US) market recorded impressive advancements.

During the last two years, several additional cannabis markets opened in the US and this is a trend that we expect to continue. From New York finally allowing for recreational cannabis sales to states being impacted by oversaturation, there are a lot of themes to be aware of.

Today, we highlighted 13 states that allow for the sale of medical and/or recreational cannabis in the US and want our readers to be aware of these markets.

1. Florida – Although recreational cannabis is not legal in Florida, the state is one of the largest cannabis markets in the US. We consider Florida to be one of the most attractive long-term opportunities in the US
2. New York – A few weeks ago, the state began to allow for the sale of recreational cannabis and we find the market to be attractive due to the size of the population
3. New Jersey – After recreational sales commenced in April 2022, the cannabis industry started to record strong growth on a quarter-over-quarter basis
4. Michigan – During the last few months, cannabis prices started to drastically decline in the state. The decline has been attributed to the market having become saturated with cannabis and we will monitor this trend from here
5. Illinois – After recording more than $1.5 billion of recreational cannabis sales in 2022, we are hoping to see the state set a new record in 2023
6. Arizona – Last year, recreational cannabis sales started to impact medical cannabis sales and we will be following this trend on a going forward basis
7. Nevada – After the state granted licenses for consumption lounges in Las Vegas, we expect this vertical of the cannabis industry to be a bright spot in 2023
8. California – Although the state is the world’s largest cannabis market, the industry faces many challenges. We prefer some markets in California more than others and believe some businesses are better positioned than others as a result
9. New Mexico – In December, the state generated a record amount of recreational cannabis sales and we will monitor how the market grows in 2023 and beyond
10. Missouri – Last year, the state legalized recreational cannabis and we expect this to be a catalyst for companies that are levered to it.
11. Ohio – According to the Ohio Medical Marijuana Control Program, the state officially sold more than $1 billion of medical cannabis products since dispensaries began to serve patients in April 2019. We believe the state’s cannabis industry is flying under the radar and will monitor how the market grows from here
12. Colorado – 2022 was a down year for the country’s first recreational cannabis market and this is a trend that our readers should be aware of. Although sales declined when compared to 2021, the state still sold approx. $1.8 billion of cannabis
13. West Virginia – The state has attracted some of the largest multi-state operators (MSOs) in the country and we consider it to be an emerging market

If you are interested in learning about companies that are levered to certain markets in the US, please send an email to support@technical420.com with the subject “Emerging Cannabis Operators” to be added to our distribution list.

Company Relationship Disclosure

T420 is responsible for the T420 opinions provided in this disclosure except all sources or information provided by other parties were not verified or authenticated and T420 does not undertake to confirm or substantiate or be responsible for such information provided by other parties.

Any Content posted regarding a Profiled Issuer is not a solicitation or recommendation to buy, sell or hold securities. We cannot and do not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. All information should be independently verified. We are not responsible for errors or omissions in our publications, and any opinions expressed are subject to change, without notice. We do not, nor are we under any obligation to undertake due diligence or investigation or authenticate and verify whatsoever regarding Profiled Issuers or any Content posted in relation thereto and we do not receive any verification from the Profiled Issuer regarding the Content we disseminate. Similarly, while we endeavor to facilitate the provision of quality information, we are not responsible for any loss or damages caused or alleged to have been caused by its use nor verify or authenticate or update such information

This article contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs regarding future performance are “forward-looking statements”. Forward-looking statements can be identified by the use of words such as “expects”, “does not expect”, “is expected”, “believes”, “intends”, “anticipates”, “does not anticipate”, “believes” or variations of these words, expressions or statements, that certain actions, events or results “may”, “could”, “would”, “might” or “will be” taken, will occur or will be realized. Such forward-looking statements involve risks, uncertainties and other known and unknown factors that could cause actual results, events or developments to differ materially from the results, events or developments expected and expressed or implied in such forward-looking statements. These risks and uncertainties include, but are not limited to, dependence on obtaining and maintaining regulatory approvals, including the acquisition and renewal of federal, provincial, state, municipal, local or other licenses, and any inability to obtain all necessary government authorizations, licenses and permits to operate and expand the Company’s facilities; regulatory or policy changes such as changes in applicable laws and regulations, including federal, state and provincial legalization, due to fluctuations in public opinion, industry perception of integrative mental health, including the use of psychedelic-assisted therapy, delays or inefficiencies or any other reason; any other factor or development likely to hamper the growth of the market; the Company’s limited operating and profitability track record; dependence on management; the Company’s need for additional financing and the effects of financial market conditions and other factors on the availability of capital; competition, including that of more established and better funded competitors; the impact of the Russia-Ukraine conflict on the global economy; the continued impact of the COVID-19 pandemic; and the need to build and maintain alliances and partnerships, including with research and development companies, customers and suppliers. These factors should be carefully considered, and readers are cautioned not to place undue reliance on forward-looking statements. Despite the Company’s efforts to identify the main risk factors that could cause actual measures, events or results to differ materially from those described in forward-looking statements, other risk factors may cause measures, events or developments to materially differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company does not undertake to revise forward-looking statements, even if new information becomes available as a result of future events, new facts or any other reason, except as required by applicable laws

Share

Tags

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Technical420.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.

Top Stories